SGLT2 Inhibitors As First Line Therapy to Prevent Renal Decline in Type 2 Diabetes
Clinical trial NCT05345327 · RECRUITING
Trial details
- NCT number
- NCT05345327
- Sponsor
- The George Institute
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-01
- Primary completion
- 2026-06-30
- Enrollment
- 994
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.